P-tau231 as a Diagnostic Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis

OBJECTIVE: Some previous studies have shown that cerebrospinal fluid (CSF) levels of p-tau231 were significantly higher in patients with Alzheimer's disease (AD) compared to that in patients with mild cognitive impairment (MCI) and normal control (NC), whereas some other studies did not. Due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabizadeh, Fardin, Salehi, Negin, Ramezannezhad, Elham, Sadeghmousavi, Shaghayegh, Khalili, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
AIAN Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764878/
https://www.ncbi.nlm.nih.gov/pubmed/36560987
http://dx.doi.org/10.4103/aian.aian_77_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764878/
https://www.ncbi.nlm.nih.gov/pubmed/36560987
http://dx.doi.org/10.4103/aian.aian_77_22

Ejemplares similares